Subscribe to Search results

Kevin Slater was 20 years old when his AIDS symptoms were first identified and just 22 years old when he died in 1985.

Published on:

In his statement to the Haemophilia Society, Professor Bloom stated that he was "unaware of any proven case" of AIDS among people with haemophilia in the UK.

Published on:

The Communicable Disease Surveillance Centre ("CDSC") published a weekly report observing Kevin Slater's case as"This is the first report of AIDS in a patient with haemophilia in the United Kingdom known to CDSC."

Published on:

Dr Nicol Spence Galbraith (CDSC), notified the DHSS regarding the report of AIDS in a patient with haemophilia in the United Kingdom.

Published on:

Dr Galbraith (PHLS) concluded in a letter to Dr Ian Field (DHSS) that all products made from blood donated in the USA after 1978 should be withdrawn from use.

Published on:

Dr Walford, wrote a memo to Dr Field regarding Dr Galbraith's conclusion on the withdrawal of all blood products from donated blood in the USA.

Published on:

Professor Bloom stated in a letter to the haemophilia centres directors "I hope that it will be possible rapidly to vary the Product Licence for relevant imported products to take account of these recent developments."

Published on:

The Council of Europe issued its recommendations which included avoiding, the use of coagulation factor concentrates prepared from large plasma pools and informing people with haemophilia of the potential health hazards of haemotherapy and the possibilities of minimising these risks.

Published on:

At the Hepatitis Working Party's meeting the position in relation to the occurence of cases of AIDS in haemophilia A patients treated with commercial factor concentrates was reviewed. It was stated that there had been two cases of the syndrome in the UK.

Published on:

Dr Delamore stated that he appreciated that the freeze-dried preparations were much more suitable for home treatment, which he now hoped to institute in selected cases.

Published on:

Except for two patients on a period of prophylaxis with commercial concentrate noted below, all 10 other severe haemophiliac participants were treated with NHS freeze-dried factor-VIII concentrate prepared by the Lister Institute Laboratories.

Published on:

Inquiry publishes financial annual report

Published on:

The 1977 annual return from the Oxford Haemophilia Centre recorded no use of cryoprecipitate at all and greater use of commercial concentrates than NHS.

Published on:

In 1979, return records show no cryoprecipitate; a small amount of Elstree Factor 8; 1,078,110 units of Oxford Factor 8; and 906,830 units of commercial (Factorate, Koate, Hemofil).

Published on:

The Belfast Haemophilia Centre, based at Royal Victoria Hospital (RVI), was designated as a reference centre.

Published on:

Paul Winstanley wrote a note on the imports of blood products into the United Kingdom for medical purposes to Dr Walford and Mrs Walden.

Published on:

A paper was presented by Dr Craske at the meeting of the UK Haemophilia Reference Centre Directors, updating the situation regarding AIDS. It was agreed that the patients who had received the same batches of NHS or commercial Factor 8 as the patient who died in Bristol should be followed up.

Published on:

A paper on AIDS Investigation was prepared by Dr Craske for the UK Haemophilia Centre Directors.

Published on:

Dr Craske presented this 'Appendix B Surveillance of AIDS cases in patients with blood coagulation disorders' paper which had been pre-circulated to directors.

Published on:

The President of the British Society for Haematology decided that a Working Party should be formed "to investigate the problem of Aids in relation to the practice of Haematology in the Diagnostic Laboratory."

Published on: